logo

For the Inventor, By the Inventor

Belmont, MA, United States of America

Andrew L Salzman

USPTO Granted Patents = 20

 

Average Co-Inventor Count = 3.4

ph-index = 9

Forward Citations = 238(Granted Patents)


Location History:

  • Belmont, MA (US) (2001 - 2011)
  • Herzliya, IL (2012 - 2013)

Company Filing History:

goldMedal17 out of 37 
 
Inotek Pharmaceuticals Corporation
 patents
silverMedal2 out of 3 
 
Inotek Corporation
 patents
bronzeMedal1 out of 1 
 
Inotek Pharmaceutical Corporation
 patent
4. 1 out of 1,168 
 
Yeda Research and Develpment & Co. Ltd
 patents
where one patent can have more than one assignee

Years Active: 2001-2013

Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents
1. 8609833 - Purine derivatives as adenosine A1 receptor agonists and methods of use thereof (2013-12-17),
2. 8263078 - Antibodies against flagellin and uses thereof (2012-09-11),
3. 8183224 - [object Object] (2012-05-22),
4. 8173130 - Antibodies against flagellin and uses thereof (2012-05-08),
5. 8133880 - Purine derivatives and methods of use thereof (2012-03-13),
6. 7863253 - Purine Derivatives and methods of use thereof (2011-01-04),
7. 7732424 - Purine derivatives and methods of use thereof (2010-06-08),
8. 7423144 - [object Object] (2008-09-09),
9. 7268143 - Isoquinoline derivatives and methods of use thereof (2007-09-11),
10. 7135491 - 5-Aryltetrazole compounds and uses thereof (2006-11-14),
11. 7078423 - 5-Aryltetrazole compounds, compositions thereof, and uses therefor (2006-07-18),
12. 6958324 - Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease (2005-10-25),
13. 6956035 - Isoquinoline derivatives and methods of use thereof (2005-10-18),
14. 6903079 - Nucleoside compounds and compositions thereof (2005-06-07),
15. 6828319 - Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof (2004-12-07),

Title: Unveiling the Innovation Journey of Andrew L Salzman

Introduction:

Andrew L Salzman, a prolific inventor hailing from Belmont, MA (US), has made significant contributions to the field of pharmaceuticals with an impressive portfolio of 20 patents. His groundbreaking work has revolutionized the treatment of various medical conditions, showcasing his brilliance as an inventor.

Latest Patents:

1. Purine derivatives as adenosine A1 receptor agonists: Salzman's inventive concept revolves around Purine Derivatives and their efficacy in reducing an animal's rate of metabolism, protecting the heart against myocardial damage, and combating cardiovascular diseases, among others.

2. Antibodies against flagellin: Salzman's innovation introduces monoclonal antibodies that exhibit high-affinity neutralizing reactivity to flagellin, offering novel methods for treating inflammatory bowel disease and enterobacterial infections.

Career Highlights:

Salzman's journey in the realm of innovation led him to prestigious companies like Inotek Pharmaceuticals Corporation and Inotek Corporation. At these organizations, he showcased his expertise and played a pivotal role in advancing pharmaceutical research and development.

Collaborations:

During his tenure, Andrew L Salzman worked alongside esteemed individuals such as Csaba Szabo and Prakash Jagtap. These collaborations not only enriched his projects but also fostered a culture of innovation and excellence in the workplace.

Conclusion:

In conclusion, Andrew L Salzman's remarkable ingenuity and dedication have left an indelible mark on the pharmaceutical landscape. His relentless pursuit of innovation, coupled with his collaborative spirit, underscores his commitment to advancing healthcare solutions. Salzman's patents stand as a testament to his unwavering passion for invention, making him a beacon of inspiration for aspiring inventors worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…